Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.670
+0.070 (2.69%)
May 2, 2025, 4:00 PM EDT - Market closed
Mereo BioPharma Group Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$7.71
Upside
+188.76%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Apr 9, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $7 | Buy | Initiates | $7 | +162.17% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +162.17% | Mar 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Jan 13, 2025 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +274.53% | Dec 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Dec 17, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +162.17% | Dec 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Nov 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +162.17% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +162.17% | Sep 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +162.17% | Aug 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +162.17% | Jul 22, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +199.63% | Jun 20, 2024 |
| Baird | Baird | Buy Initiates $8 | Buy | Initiates | $8 | +199.63% | Jun 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +162.17% | Jun 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.